PROCEPT BioRobotics (PRCT)
PROCEPT BioRobotics on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus.
7.5M
Short interest
settlement 2026-10-15
5.6
Days to cover
+0.3 days vs prior
40.1%
Short share of volume
2026-11-02
4,929
Fails to deliver
settlement 2026-10-06
Tue 3 Nov
Next earnings
estimated date
$476K
Insider flow, 90 days
1 buys, 3 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in PRCT is 7,501,644 shares, up 61,468 shares over the last month. Over the last 48 readings it ranged from 5,079,251 shares (28 February 2025) to 8,504,080 shares (30 September 2025). At the reported average volume of 1.3M shares a day that is 5.6 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/prct" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 7,501,644 | +1.0% | 1,345,726 | 5.57 |
| 2026-09-30 | 7,427,237 | -0.2% | 1,396,991 | 5.32 |
| 2026-09-15 | 7,440,176 | +2.6% | 1,339,103 | 5.56 |
| 2026-08-31 | 7,248,594 | -5.9% | 846,305 | 8.56 |
| 2026-08-14 | 7,705,034 | +8.7% | 2,220,311 | 3.47 |
| 2026-07-31 | 7,091,454 | -8.5% | 1,384,854 | 5.12 |
| 2026-07-15 | 7,753,703 | +1.3% | 1,587,411 | 4.88 |
| 2026-06-30 | 7,654,020 | +0.6% | 1,968,674 | 3.89 |
| 2026-06-15 | 7,610,362 | +12.2% | 1,402,363 | 5.43 |
| 2026-05-29 | 6,782,226 | +0.9% | 1,258,463 | 5.39 |
| 2026-05-15 | 6,720,680 | +11.9% | 1,667,271 | 4.03 |
| 2026-04-30 | 6,004,339 | +3.0% | 1,447,861 | 4.15 |
| 2026-04-15 | 5,832,329 | -0.6% | 1,303,896 | 4.47 |
| 2026-03-31 | 5,867,315 | -9.8% | 1,240,086 | 4.73 |
| 2026-03-13 | 6,504,659 | +1.8% | 2,438,372 | 2.67 |
| 2026-02-27 | 6,387,391 | -8.7% | 2,487,794 | 2.57 |
| 2026-02-13 | 6,997,820 | -2.7% | 1,158,172 | 6.04 |
| 2026-01-30 | 7,189,150 | +9.2% | 1,158,856 | 6.20 |
| 2026-01-15 | 6,582,770 | -2.1% | 1,067,638 | 6.17 |
| 2025-12-31 | 6,724,005 | +10.6% | 1,054,989 | 6.37 |
| 2025-12-15 | 6,081,396 | -10.5% | 1,682,792 | 3.61 |
| 2025-11-28 | 6,791,522 | +0.1% | 1,527,411 | 4.45 |
| 2025-11-14 | 6,784,186 | -10.9% | 1,912,279 | 3.55 |
| 2025-10-31 | 7,614,889 | -6.6% | 1,196,483 | 6.36 |
| 2025-10-15 | 8,154,319 | -4.1% | 1,118,468 | 7.29 |
| 2025-09-30 | 8,504,080 | +4.4% | 941,956 | 9.03 |
| 2025-09-15 | 8,145,600 | -2.7% | 1,052,657 | 7.74 |
| 2025-08-29 | 8,370,315 | +3.8% | 812,031 | 10.31 |
| 2025-08-15 | 8,067,967 | +13.3% | 1,684,559 | 4.79 |
| 2025-07-31 | 7,119,045 | +4.3% | 1,391,361 | 5.12 |
| 2025-07-15 | 6,823,424 | +0.2% | 709,500 | 9.62 |
| 2025-06-30 | 6,808,235 | +1.4% | 702,830 | 9.69 |
| 2025-06-13 | 6,716,837 | +10.1% | 873,076 | 7.69 |
| 2025-05-30 | 6,103,496 | +3.5% | 855,706 | 7.13 |
| 2025-05-15 | 5,896,227 | +1.4% | 822,218 | 7.17 |
| 2025-04-30 | 5,814,592 | -4.2% | 1,423,542 | 4.08 |
| 2025-04-15 | 6,072,298 | -4.2% | 1,043,394 | 5.82 |
| 2025-03-31 | 6,336,415 | +8.7% | 831,729 | 7.62 |
| 2025-03-14 | 5,829,532 | +14.8% | 1,015,087 | 5.74 |
| 2025-02-28 | 5,079,251 | -10.7% | 1,234,439 | 4.11 |
| 2025-02-14 | 5,684,573 | -5.0% | 686,795 | 8.28 |
| 2025-01-31 | 5,980,863 | -15.4% | 1,137,185 | 5.26 |
| 2025-01-15 | 7,073,409 | +2.7% | 640,612 | 11.04 |
| 2024-12-31 | 6,885,494 | +11.4% | 549,775 | 12.52 |
| 2024-12-13 | 6,178,750 | +1.4% | 514,363 | 12.01 |
| 2024-11-29 | 6,090,551 | -4.4% | 464,651 | 13.11 |
| 2024-11-15 | 6,368,412 | +8.0% | 926,209 | 6.88 |
| 2024-10-31 | 5,896,747 | -12.1% | 1,414,993 | 4.17 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of PRCT volume is 40.1%, down 10.7 points over the last five sessions. Over the last 30 readings it ranged from 19.1% (28 September 2026) to 72.8% (23 September 2026). The latest reading is 10.2 points below the 30-session average of 50.3%, on 430K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 172K | 430K | 40.1% | 0 |
| 2026-10-30 | 143K | 324K | 44.2% | 0 |
| 2026-10-29 | 71K | 168K | 42.2% | 1,576 |
| 2026-10-28 | 144K | 288K | 49.8% | 0 |
| 2026-10-27 | 76K | 207K | 36.9% | 8 |
| 2026-10-26 | 113K | 224K | 50.7% | 0 |
| 2026-10-23 | 131K | 268K | 48.7% | 0 |
| 2026-10-22 | 244K | 411K | 59.5% | 22 |
| 2026-10-21 | 119K | 249K | 48.0% | 169 |
| 2026-10-20 | 214K | 329K | 65.0% | 38,510 |
| 2026-10-19 | 198K | 359K | 55.1% | 0 |
| 2026-10-16 | 198K | 355K | 55.7% | 0 |
| 2026-10-15 | 124K | 351K | 35.2% | 0 |
| 2026-10-14 | 257K | 601K | 42.8% | 1 |
| 2026-10-13 | 334K | 737K | 45.3% | 336 |
| 2026-10-12 | 476K | 807K | 58.9% | 447 |
| 2026-10-09 | 138K | 278K | 49.5% | 284 |
| 2026-10-08 | 129K | 274K | 47.3% | 401 |
| 2026-10-07 | 191K | 330K | 58.0% | 0 |
| 2026-10-06 | 138K | 276K | 49.9% | 0 |
| 2026-10-05 | 169K | 334K | 50.7% | 664 |
| 2026-10-02 | 257K | 546K | 47.0% | 3 |
| 2026-10-01 | 337K | 537K | 62.9% | 0 |
| 2026-09-30 | 235K | 451K | 52.1% | 208 |
| 2026-09-29 | 387K | 777K | 49.8% | 0 |
| 2026-09-28 | 138K | 726K | 19.1% | 0 |
| 2026-09-25 | 344K | 778K | 44.2% | 2,620 |
| 2026-09-24 | 364K | 539K | 67.5% | 0 |
| 2026-09-23 | 273K | 376K | 72.8% | 0 |
| 2026-09-22 | 241K | 406K | 59.4% | 28 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 6 October 2026, the fails-to-deliver balance in PRCT is 4,929 shares, down 27,108 shares over the last settlement date. Over the last 30 readings it ranged from 8 shares (4 August 2026) to 54,244 shares (4 September 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-06 | 4,929 | $17.82 | $88K |
| 2026-10-05 | 32,037 | $17.16 | $550K |
| 2026-09-25 | 11,181 | $17.50 | $196K |
| 2026-09-21 | 40,921 | $19.30 | $790K |
| 2026-09-18 | 39,433 | $19.47 | $768K |
| 2026-09-17 | 57 | $19.44 | $1K |
| 2026-09-15 | 18,297 | $21.02 | $385K |
| 2026-09-14 | 14,507 | $20.38 | $296K |
| 2026-09-11 | 19,339 | $20.07 | $388K |
| 2026-09-10 | 20,092 | $20.74 | $417K |
| 2026-09-08 | 46,123 | $22.76 | $1.0M |
| 2026-09-04 | 54,244 | $21.37 | $1.2M |
| 2026-08-27 | 123 | $21.07 | $3K |
| 2026-08-21 | 79 | $20.73 | $2K |
| 2026-08-19 | 2,817 | $21.32 | $60K |
| 2026-08-17 | 13,121 | $21.65 | $284K |
| 2026-08-14 | 799 | $21.95 | $18K |
| 2026-08-12 | 17 | $22.89 | $389 |
| 2026-08-11 | 6,850 | $21.71 | $149K |
| 2026-08-10 | 2,158 | $20.41 | $44K |
| 2026-08-06 | 23,574 | $19.34 | $456K |
| 2026-08-04 | 8 | $18.38 | $147 |
| 2026-07-24 | 200 | $17.55 | $4K |
| 2026-07-23 | 200 | $17.70 | $4K |
| 2026-07-22 | 200 | $18.52 | $4K |
| 2026-07-16 | 11 | $19.15 | $211 |
| 2026-07-10 | 26,164 | $19.75 | $517K |
| 2026-07-08 | 104 | $21.03 | $2K |
| 2026-06-30 | 463 | $22.58 | $10K |
| 2026-06-29 | 1,826 | $22.56 | $41K |
Insider trades
SEC Form 4, newest first. JSONOver the last 90 days PRCT insiders reported 1 open-market buy ($498K) against 3 sells ($22K), so the dollar flow leans toward buying. Latest filing: Mack Michael (Director) on 2026-10-02.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Mack Michael | Director | Grant | 8K | $0.00 | $0 | 8K |
| 2026-09-09 | Waters Kevin | EVP, CFO | Sell | 373 | $20.95 | $8K | 180K |
| 2026-09-09 | Templin Barry L | EVP, Chief Technology Officer | Sell | 373 | $20.95 | $8K | 95K |
| 2026-09-09 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Sell | 297 | $20.95 | $6K | 128K |
| 2026-08-13 | Templin Barry L | EVP, Chief Technology Officer | Grant | 26K | $0.00 | $0 | 95K |
| 2026-08-13 | Waters Kevin | EVP, CFO | Grant | 30K | $0.00 | $0 | 181K |
| 2026-08-13 | Sharma Pooja | Chief Strat/Marketing Officer | Grant | 24K | $0.00 | $0 | 111K |
| 2026-08-13 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Grant | 23K | $0.00 | $0 | 128K |
| 2026-08-07 | Wood Larry L | President, CEO | Buy | 24K | $20.85 | $498K | 24K |
| 2026-06-09 | PUCKETT DAN | Director | Grant | 3K | $0.00 | $0 | 9K |
| 2026-06-09 | PRESCOTT THOMAS M | Director | Grant | 3K | $0.00 | $0 | 7K |
| 2026-06-09 | MOLL FREDERIC H | Director | Grant | 3K | $0.00 | $0 | 866K |
| 2026-06-09 | Little Elisabeth Sandoval | Director | Grant | 3K | $0.00 | $0 | 16K |
| 2026-06-09 | Harris Taylor C. | Director | Grant | 3K | $0.00 | $0 | 102K |
| 2026-06-09 | Garrett Mary | Director | Grant | 3K | $0.00 | $0 | 18K |
| 2026-06-09 | Dodrill Amy M. | Director | Grant | 3K | $0.00 | $0 | 11K |
| 2026-06-09 | Desai Antal Rohit | Director | Grant | 3K | $0.00 | $0 | 38K |
| 2026-06-08 | Waters Kevin | EVP, CFO | Sell | 357 | $28.48 | $10K | 151K |
| 2026-06-08 | Templin Barry L | EVP, Chief Technology Officer | Sell | 358 | $28.48 | $10K | 69K |
| 2026-06-08 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Sell | 285 | $28.48 | $8K | 105K |
| 2026-03-19 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Sell | 2K | $26.15 | $61K | 105K |
| 2026-03-19 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Sell | 3K | $25.82 | $78K | 108K |
| 2026-03-17 | Waters Kevin | EVP, CFO | Sell | 706 | $28.15 | $20K | 152K |
| 2026-03-17 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Sell | 304 | $28.15 | $9K | 111K |
| 2026-03-10 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Sell | 145 | $26.74 | $4K | 111K |
| 2026-03-10 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Sell | 3K | $25.60 | $79K | 111K |
| 2026-03-09 | Desai Antal Rohit | Director | Buy | 1K | $25.42 | $33K | 426K |
| 2026-03-09 | Desai Antal Rohit | Director | Buy | 54K | $24.91 | $1.3M | 425K |
| 2026-03-09 | Desai Antal Rohit | Director | Buy | 44K | $24.08 | $1.0M | 371K |
| 2026-03-06 | Waters Kevin | EVP, CFO | Sell | 7K | $23.70 | $159K | 152K |
| 2026-03-06 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Sell | 7K | $23.70 | $163K | 114K |
| 2026-03-06 | Desai Antal Rohit | Director | Buy | 54K | $24.10 | $1.3M | 328K |
| 2026-03-06 | Desai Antal Rohit | Director | Buy | 107K | $23.33 | $2.5M | 274K |
| 2026-03-05 | Wood Larry L | President, CEO | Grant | 128K | $0.00 | $0 | 313K |
| 2026-03-05 | Waters Kevin | EVP, CFO | Grant | 47K | $0.00 | $0 | 159K |
| 2026-03-05 | PUCKETT DAN | Director | Grant | 5K | $0.00 | $0 | 5K |
| 2026-03-05 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Grant | 44K | $0.00 | $0 | 121K |
| 2026-03-05 | Desai Antal Rohit | Director | Buy | 25K | $26.41 | $654K | 167K |
| 2026-03-05 | Desai Antal Rohit | Director | Buy | 142K | $25.44 | $3.6M | 142K |
| 2026-02-19 | Waters Kevin | EVP, CFO | Grant | 4K | $0.00 | $0 | 112K |
| 2026-02-19 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Grant | 5K | $0.00 | $0 | 77K |
| 2025-09-02 | Wood Larry L | President, CEO | Grant | 182K | $0.00 | $0 | 186K |
| 2025-08-14 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Exercise or conversion | 11K | $4.52 | $50K | 72K |
| 2025-08-14 | Desai Antal Rohit | Director | Exercise or conversion | 27K | $1.33 | $36K | 35K |
| 2025-08-13 | MOLL FREDERIC H | Director | Buy | 20K | $39.26 | $785K | 863K |
| 2025-06-12 | Desai Antal Rohit | Director | Sell | 5K | $62.33 | $315K | 14K |
| 2025-06-12 | Desai Antal Rohit | Director | Sell | 20K | $61.28 | $1.2M | 19K |
| 2025-06-11 | Desai Antal Rohit | Director | Sell | 6K | $64.27 | $367K | 39K |
| 2025-06-11 | Desai Antal Rohit | Director | Sell | 11K | $63.47 | $730K | 45K |
| 2025-06-11 | Desai Antal Rohit | Director | Sell | 8K | $62.59 | $487K | 57K |
| 2025-06-10 | Sandoval Elisabeth | Director | Grant | 2K | $0.00 | $0 | 13K |
| 2025-06-10 | Wood Larry L | Director | Grant | 2K | $0.00 | $0 | 6K |
| 2025-06-10 | PRESCOTT THOMAS M | Director | Grant | 2K | $0.00 | $0 | 4K |
| 2025-06-10 | MOLL FREDERIC H | Director | Grant | 2K | $0.00 | $0 | 843K |
| 2025-06-10 | Harris Taylor C. | Director | Grant | 2K | $0.00 | $0 | 99K |
| 2025-06-10 | Garrett Mary | Director | Grant | 2K | $0.00 | $0 | 14K |
| 2025-06-10 | Dodrill Amy M. | Director | Grant | 2K | $0.00 | $0 | 8K |
| 2025-06-10 | Desai Antal Rohit | Director | Grant | 2K | $0.00 | $0 | 8K |
| 2025-06-10 | Desai Antal Rohit | Director | Sell | 2K | $64.67 | $112K | 64K |
| 2025-06-10 | Desai Antal Rohit | Director | Sell | 18K | $64.02 | $1.2M | 66K |
| 2025-06-10 | Desai Antal Rohit | Director | Sell | 5K | $63.23 | $307K | 85K |
| 2025-06-06 | Shiblaq Hisham | EVP, Chief Comm. Officer | Exercise or conversion | 20K | $5.18 | $104K | 83K |
| 2025-06-06 | Shiblaq Hisham | EVP, Chief Comm. Officer | Sell | 12K | $63.71 | $783K | 71K |
| 2025-06-06 | Shiblaq Hisham | EVP, Chief Comm. Officer | Sell | 6K | $64.64 | $382K | 65K |
| 2025-06-06 | Shiblaq Hisham | EVP, Chief Comm. Officer | Sell | 2K | $65.35 | $118K | 63K |
| 2025-06-05 | Desai Antal Rohit | Director | Sell | 6K | $64.19 | $382K | 106K |
| 2025-06-05 | Desai Antal Rohit | Director | Sell | 13K | $65.09 | $817K | 93K |
| 2025-06-05 | Desai Antal Rohit | Director | Sell | 4K | $65.94 | $264K | 89K |
| 2025-06-05 | Desai Antal Rohit | Director | Sell | 100 | $66.73 | $7K | 89K |
| 2025-06-05 | Desai Antal Rohit | Director | Sell | 2K | $63.07 | $108K | 112K |
| 2025-06-05 | Desai Antal Rohit | Director | Sell | 700 | $61.85 | $43K | 114K |
| 2025-06-04 | Desai Antal Rohit | Director | Sell | 16K | $60.82 | $997K | 123K |
| 2025-06-04 | Desai Antal Rohit | Director | Sell | 9K | $61.40 | $528K | 114K |
| 2025-06-03 | Desai Antal Rohit | Director | Sell | 1K | $59.14 | $65K | 162K |
| 2025-06-03 | Desai Antal Rohit | Director | Sell | 12K | $61.22 | $710K | 141K |
| 2025-06-03 | Desai Antal Rohit | Director | Sell | 10K | $60.23 | $595K | 152K |
| 2025-06-03 | Desai Antal Rohit | Director | Sell | 900 | $58.04 | $52K | 163K |
| 2025-06-03 | Desai Antal Rohit | Director | Sell | 2K | $61.83 | $94K | 139K |
| 2025-05-09 | Zadno Reza | President, CEO | Exercise or conversion | 14K | $7.27 | $100K | 187K |
| 2025-03-18 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Sell | 316 | $57.06 | $18K | 61K |
| 2025-03-18 | Shiblaq Hisham | EVP, Chief Comm. Officer | Sell | 247 | $57.06 | $14K | 63K |
| 2025-03-18 | Waters Kevin | EVP, CFO | Sell | 733 | $57.06 | $42K | 108K |
| 2025-03-18 | Zadno Reza | President, CEO | Sell | 5K | $57.06 | $312K | 173K |
| 2025-03-06 | Zadno Reza | President, CEO | Sell | 16K | $61.31 | $976K | 179K |
| 2025-03-06 | Waters Kevin | EVP, CFO | Sell | 4K | $61.31 | $225K | 109K |
| 2025-03-06 | Shiblaq Hisham | EVP, Chief Comm. Officer | Sell | 4K | $61.31 | $220K | 63K |
| 2025-03-06 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Sell | 4K | $61.31 | $223K | 62K |
| 2025-03-03 | Zadno Reza | President, CEO | Grant | 42K | $0.00 | $0 | 194K |
| 2025-03-03 | Waters Kevin | EVP, CFO | Grant | 16K | $0.00 | $0 | 112K |
| 2025-03-03 | Shiblaq Hisham | EVP, Chief Comm. Officer | Grant | 11K | $0.00 | $0 | 67K |
| 2025-03-03 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Grant | 13K | $0.00 | $0 | 65K |
| 2025-02-10 | MOLL FREDERIC H | Director | Exercise or conversion | 27K | $1.33 | $36K | 836K |
| 2025-02-10 | MOLL FREDERIC H | Director | Exercise or conversion | 5K | $0.86 | $5K | 842K |
| 2024-12-04 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Exercise or conversion | 4K | $34.99 | $146K | 68K |
| 2024-12-04 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Sell | 4K | $96.12 | $364K | 77K |
| 2024-12-04 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Exercise or conversion | 12K | $37.02 | $448K | 81K |
| 2024-12-04 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Exercise or conversion | 12K | $7.27 | $86K | 64K |
| 2024-12-04 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Sell | 8K | $97.90 | $795K | 52K |
| 2024-12-04 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Sell | 16K | $96.98 | $1.6M | 61K |
| 2024-12-04 | Zadno Reza | President, CEO | Sell | 5K | $96.15 | $510K | 174K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON12 Form 144 notices on file for PRCT worth $624K at the prices reported; 3 in the last 90 days worth $22K. Latest: Templin Barry L filed on 2026-09-09 to sell 373 shares ($8K) from 2026-09-09.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-09 | Templin Barry LOfficer | 373 | $8K | 0.001% | 2026-09-09 | Fidelity Brokerage Services LLC |
| 2026-09-09 | Waters KevinOfficer | 373 | $8K | 0.001% | 2026-09-09 | Fidelity Brokerage Services LLC |
| 2026-09-09 | Nouri AlalehOfficer | 297 | $6K | 0.001% | 2026-09-09 | Fidelity Brokerage Services LLC |
| 2026-06-08 | Waters KevinOfficer | 357 | $10K | 0.001% | 2026-06-08 | Fidelity Brokerage Services LLC |
| 2026-06-08 | Templin Barry LOfficer | 358 | $10K | 0.001% | 2026-06-08 | Fidelity Brokerage Services LLC |
| 2026-06-08 | Nouri AlalehOfficer | 285 | $8K | 0.001% | 2026-06-08 | Fidelity Brokerage Services LLC |
| 2026-03-19 | Alalah NouriOfficer | 5K | $140K | 0.010% | 2026-03-19 | J.P. Morgan Securities LLC |
| 2026-03-17 | Waters KevinOfficer | 706 | $20K | 0.001% | 2026-03-17 | Fidelity Brokerage Services LLC |
| 2026-03-17 | Nouri AlalehOfficer | 304 | $9K | 0.001% | 2026-03-17 | Fidelity Brokerage Services LLC |
| 2026-03-10 | Alalah NouriOfficer | 3K | $82K | 0.006% | 2026-03-10 | J.P. Morgan Securities LLC |
| 2026-03-06 | Waters KevinOfficer | 7K | $159K | 0.012% | 2026-03-06 | Fidelity Brokerage Services LLC |
| 2026-03-06 | Nouri AlalehOfficer | 7K | $163K | 0.012% | 2026-03-06 | Fidelity Brokerage Services LLC |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON3 holders report 5% or more of PRCT in their latest filing, all on Schedule 13G (passive). The largest reported stake is BlackRock, Inc. at 8.2% of the class (4,646,656 shares), filed 2026-07-29 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-30 | 13G/Ano. 1 | Vanguard Capital Managementinvestment adviser | 2.8M | 5.0% | 2026-09-30 |
| 2026-07-29 | 13G/Ano. 1 | BlackRock, Inc.parent holding company | 4.6M | 8.2% | 2026-06-30 |
| 2026-05-18 | 13G/Ano. 1 | AllianceBernstein L.P.investment adviser | 147K | 0.3% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 4 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-03-06 | 13G/Ano. 5 | FMR LLCparent holding company | 1.6M | 2.9% | 2026-02-27 |
| 2026-03-06 | 13G/Ano. 5 | Abigail P. Johnsonindividual | 1.6M | 2.9% | 2026-02-27 |
| 2026-02-17 | 13G | T. Rowe Price Investment Management, Inc.investment adviser | 3.3M | 5.9% | 2025-12-31 |
| 2026-02-11 | 13G | BNP Paribas Asset Management Holding S.A.parent holding company | 3.1M | 5.5% | 2025-12-31 |
13F holders
Tracked managers holding PRCT at their latest 13F. JSON4 of the 30 tracked managers held PRCT at their latest 13F, $23.9M in total at quarter-end prices. Millennium Management is the largest at $14.1M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 624K | $14.1M | 0.01% | -381K |
| AQR Capital Management | 2026-06-30 | 370K | $8.4M | 0.00% | +115K |
| Two Sigma Investments | 2026-06-30 | 51K | $1.2M | 0.00% | -178K |
| Citadel Advisors | 2026-06-30 | 13K | $285K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) PROCEPT BioRobotics reported revenue of $94.5M, up 19.3% from the same quarter a year earlier, and net loss of $26.9M (-0.47 diluted EPS). In FY 2025 it generated -$49.0M of operating cash flow. As of 2026-06-30, cash was $227.9M against $51.7M of debt.
- Cash
- $227.9M
- Debt
- $51.7M
- Equity
- $340.1M
- Total assets
- $479.4M
- Shares outstanding
- 57,273,659
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $94.5M | -$26.9M | -28.4% | -0.47 |
| Q1 FY 2026 | 2026-03-31 | $83.1M | -$31.6M | -38.1% | -0.56 |
| Q4 FY 2025derived | 2025-12-31 | $76.4M | n/a | n/a | n/a |
| Q3 FY 2025 | 2025-09-30 | $83.3M | -$21.4M | -25.7% | -0.38 |
| Q2 FY 2025 | 2025-06-30 | $79.2M | -$19.6M | -24.7% | -0.35 |
| Q1 FY 2025 | 2025-03-31 | $69.2M | -$24.7M | -35.8% | -0.45 |
| Q4 FY 2024derived | 2024-12-31 | $68.2M | n/a | n/a | n/a |
| Q3 FY 2024 | 2024-09-30 | $58.4M | -$21.0M | -35.9% | -0.40 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $308.1M | -$96K | -$49.0M | $9.4M | n/a | n/a |
| FY 2024 | 2024-12-31 | $224.5M | -$91K | -$99.2M | $4.4M | n/a | n/a |
| FY 2023 | 2023-12-31 | $136.2M | -$106K | -$108.0M | $25.2M | n/a | n/a |
| FY 2022 | 2022-12-31 | $75.0M | -$87K | -$80.4M | $2.7M | n/a | n/a |
| FY 2021 | 2021-12-31 | $34.5M | -$60K | -$57.3M | $592K | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-31 from the cover page.
What this page is
PROCEPT BioRobotics in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows PROCEPT BioRobotics (PRCT), SEC CIK 1588978, listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-06.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-09.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-30.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-04.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-02.JSON and CSV
- Company record
- EDGAR filing index for CIK 1588978Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as surgical & medical instruments & apparatus
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of PRCT is sold short?
What is PRCT's daily short volume?
Does PRCT have fails to deliver?
Are PRCT insiders buying or selling?
Have PRCT insiders filed to sell?
Who owns 5% or more of PRCT?
What did PRCT report last quarter?
Which tracked 13F managers own PRCT?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.